Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer

Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal cancer who have registered progression or intolerance to treatment with fluoropyrimidines, oxaliplatin and irinotecan, anti-VEGRand anti-EGF...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: M. Yu. Fedyanin, F. V. Moiseenko, D. A. Chekini, V. A. Chubenko, A. S. Zhabina, L. A. Zagorskaya, M. M. Kramchaninov, S. A. Tjulandin, V. M. Moiseyenko
Format: Artigo
Sprog:Russo
Udgivet: Remedium Group LLC 2020-12-01
Serier:Медицинский совет
Fag:
trifluridine/tipiracil
tas-102
metastatic cancer
colorectal
chemotherapy
targeted therapy
Online adgang:https://www.med-sovet.pro/jour/article/view/5934
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker